1 authorised product containing Blinatumomab, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| BLINCYTO 38.5 micrograms powder for concentrate and solution for solution for infusion EU/1/15/1047/001 |
Blinatumomab | Amgen Europe B.V., | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.